Powder: -20°C for 3 years | In solvent: -80°C for 2 years
MSDC-0602K (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM. It also modulates the mitochondrial pyruvate carrier (MPC). This compound, MSDC-0602K, has potential applications in researching fatty liver conditions, including dysfunctional lipid metabolism, inflammation, and insulin resistance. MSDC-0602K acts as an insulin sensitizer, improving insulinemia and fatty liver disease in mice both individually and in combination with Liraglutide.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
5 mg | In stock | $ 143.00 | |
10 mg | In stock | $ 228.00 | |
25 mg | In stock | $ 463.00 | |
50 mg | In stock | $ 738.00 | |
100 mg | In stock | $ 987.00 | |
500 mg | In stock | $ 1,980.00 |
Description | MSDC-0602K (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM. It also modulates the mitochondrial pyruvate carrier (MPC). This compound, MSDC-0602K, has potential applications in researching fatty liver conditions, including dysfunctional lipid metabolism, inflammation, and insulin resistance. MSDC-0602K acts as an insulin sensitizer, improving insulinemia and fatty liver disease in mice both individually and in combination with Liraglutide. |
Targets&IC50 | PPAR-γ:18.25 μM |
In vivo | Diabetic db/db and MS-NASH mice are treated with MSDC-0602K by oral gavage, Liraglutide by s.c. injection, or combination MSDC-0602K + Liraglutide. This combination treatment may be an effective therapeutic strategy for diabetes and non-alcoholic steatohepatitis. Animal Model: Five-week-old male db/db mice on C57BL/6J background and age/sex-matched db/+ control mice [1] Dosage: 30 mg/kg MSDC-0602K; 0.2 mg/kg Liraglutide Administration: MSDC-0602K gavage daily, Liraglutide s.c. every other day, or combined MSDC-0602K+ Liraglutide Result: MSDC-0602K corrected glycemia and reduced insulinemia when given alone, or in combination with Liraglutide. However, MSDC-0602K + Liraglutide combination more significantly improved glucose tolerance and liver histology[1]. |
Synonyms | Azemiglitazone potassium |
Molecular Weight | 409.5 |
Formula | C19H16KNO5S |
CAS No. | 1314533-27-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MSDC-0602K 1314533-27-1 DNA Damage/DNA Repair Metabolism PPAR Azemiglitazone potassium inhibitor inhibit